Group I secreted PLA2 in the maintenance of human lower esophageal sphincter tone

Gastroenterology

Volumn 119, Issue 5, 2000, Pages 1243-1252

  Biancani, Piero ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A; PHOSPHOLIPASE C; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN KINASE C;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME SPECIFICITY; HUMAN; LOWER ESOPHAGUS SPHINCTER; METABOLISM; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE TONE; PHYSIOLOGY;

ADOLESCENT; ADULT; AGED; CYCLOOXYGENASE INHIBITORS; ENZYME INHIBITORS; ESOPHAGOGASTRIC JUNCTION; GTP-BINDING PROTEINS; HUMANS; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE TONUS; PHOSPHATIDYLCHOLINES; PHOSPHOLIPASE C; PHOSPHOLIPASES A; PROTEIN KINASE C; SUBSTRATE SPECIFICITY;

EID: 0034323059     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2000.19581     Document Type: Article

References (60)

1. Behar J, Kerstein M, Biancani P. Neural control of the lower esophageal sphincter in the cat: studies on the excitatory pathways to the lower esophageal sphincter. Gastroenterology 1982; 82:680-688.
2. Christensen J, Conklin JL, Freeman BW. Physiologic specialization at the esophagogastric junction in three species. Am J Physiol 1973;225:1265-1270.
3. Goyal RK, Rattan S. Genesis of basal sphincter pressure: effect of tetrodotoxin on lower esophageal sphincter pressure in opossum in vivo. Gastroenterology 1976;71:62-67.
4. Preiksaitis H, Diamant N. Phasic contractions of the muscular components of human esophagus and gastroesophageal junction in vitro. Can J Physiol Pharmacol 1995;73:356-363.
5. Preiksaitis H, Diamant N. Regional differences in cholinergic activity of muscle fibers from the human gastroesophageal junction. Am J Physiol 1997;272:G I321-GI327.
6. Cao WB, Harnett KM, Chen Q, Jain MK, Behar J, Biancani P. Group I secreted PLA2 (sPLA2) and arachidonic acid metabolites in the maintenance of cat LES tone. Am J Physiol 1999;277: G585-G598.
7. Sohn UD, Harnett KM, De Pétris G, Behar J, Biancani P. Distinct muscarinic receptors, G-proteins, and phospholipases in esophageal and lower esophageal sphincter circular muscle. J Pharmacol Exp Ther 1993;267:1205-1214.
8. Sohn UD, Harnett KM, Cao W, Rich H, Kirn N, Behar J, Biancani P. Acute experimental esophagitis activates a second signal transduction pathway in cat smooth muscle from the lower esophageal sphincter. J Pharmacol Exp Ther 1997;283:1293-1304.
9. Biancani P, Harnett KM, Sohn UD, Rhim BY, Behar J, HillemeierC, Bitar KN. Differential signal transduction pathways in LES tone and response to ACh. Am J Physiol 1994;266:G767-G774.
10. Hillemeier AC, Bitar KB, Sohn UD, Biancani P. Protein kinase C mediates spontaneous tone in the cat lower esophageal sphincter. J Pharmacol Exp Ther 1996;277:144-149.
11. Sohn UD, Zoukhri D, Dartt D, Sergheraert C, Harnett KM, Behar J, Biancani P. Different PKC isozymes mediate lower esophageal sphincter (LES) tone and phasic contraction of esophageal (ESO) circular smooth muscle in the cat. Mol Pharmacol 1997;51:462470.
12. Dennis EA. Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem 1994;269:13057-13060.
13. Dennis EA. The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biol Sei 1997;22:l-2.
14. Kudo I, Murakami M, Hara S, Inoue K. Mammalian non-pancreatic phospholipases A2. Biochim Biophys Acta 1993;1170:217231.
15. Sohn UD, Kim DK, Bonventre JV, Behar J, Biancani P. Role of 100 kDa cytosolic PU\2 in ACh-induced contraction of esophageal circular muscle. Am J Physiol 1994;267:G433-G441.
16. Davidson FF, Dennis HA. Evolutionary relationships and implications for the regulation of phospholipase A2 from snake venom to human secreted forms. J Mol Evol 1990:31:228-238.
17. Heinrikson RL, Krueger ET, Keim PS. Amino acid sequence of phospholipase A2-alpha from venom of Crotalus adamanteus. A new classification of phospholipase A2 based upon structural determinations. J Biol Chem 1977;252:4913-4921.
18. Tischfield JA. A reassessment of the low molecular weight phospholipase A2 gene family in mammals. J Biol Chem 1997;272: 17247-17250.
19. Van den Bosch H, Aarsman AJ, de Jong JGN, Arnoldussen E, Neys FW, Wasenaar PD. Immunoaffinity purification, partial sequence, and subcellular localization of rat liver phospholipase A2. J Biol Chem 1989;264:10008-10014.
20. Matsuda Y, Ogawa M, Shibata T, Nakaguchi K, Nishijima J, Wakasugi C, Mori T. Distribution of immunoreactive pancreatic phospholipase A2 (IPPL-2) in various human tissues. Res Commun Chem Pathol Pharmacol 1987:58:281-284.
21. Seilhamer J, Randall T, Yamanaka M, Johnson L. Pancreatic phospholipase A2: isolation of the human gene and cDNAs from porcine pancreas and human lung. DNA 1986:6:519-527.
22. Tojo H, Ono T, Kuramitsu S, Kangamiyama H, Okamoto M. A phospholipase A2 in the supernatent fraction of rat spleen. Its similarity to rat pancreatic phospholipase A2. J Biol Chem 1988; 263:5724-5731.
23. Arita H, Hanasaki K, Nakano T, Oka S, Teraoka H, Matsumoto K. Novel proliferative effect of phospholipase A2 in Swiss 3T3 cells via specific binding site. J Biol Chem 10991:266:19139-19141.
24. Nakajima M, Hanasahi K, Ueda M, Arita H. Effect of pancreatic type phospholipase A2 on isolated porcine cerebral arteries via its specific binding sites. FEBS Lett 1992:309:261-264.
25. Sommers C D, Bobbitt JL, Bemis KG, Snyder DW. Porcine pancreatic phospholipas6- A2-induced contractions of guinea pig lung pleural strips. Eur J Pharmacol 1992;216:87-96.
26. Lanas A, Hirschowitz BL. Significant role of aspirin use in patients with esophagitis. J Clin Gastroenterol 1991:13:622-627.
27. Hirschowitz Bl. Nonsteroidal anti-inflammatory drugs and the gut. South Med J 1996;8£:259-263.
28. Biancani P, Hillemeier C, Bitar KN, Makhlou GM. Contraction mediated by Ca++ influx in the esophagus and by Ca++ release in the LES. Am J Physiol 1987:253:G760-G766.
29. Biancani P, Zabinski M, Kerstein M, Behar J. Lower esophageal sphincter mechanics: anatomic and physiologic relationships of the esophagogastric junction of the cat. Gastroenterology 1982; 82:468-475.
30. Biancani P, Walsh JH, Behar J. Vasoactive intestinal polypeptide: a neurotransmitter for lower esophageal sphincter relaxation. J Clin Invest 1984;73 963-967.
31. Biancani P, Billett G, Hillemeier C, Nissenshon M, Rhim BY, Sweczack S, Behar J Acute experimental esophagitis impairs signal transduction in cat LES circular muscle. Gastroenterology 1992;103:1199-1205.
32. Rich H, Sohn UD, Behar J, Biancani P. Experimental esophagitis affects intracellular calcium stores in the cat lower esophageal sphincter. Am J Physiol 1997;272:G1523-G1529.
33. Sohn UD, Chiu TT, Bitar KN, Hillemeier C. Calcium requirements for ACh induced contraction of cat esophageal circular muscle cells. Am J Physiol 1994;266:G330-G338.
34. Sohn UD, Han B, Tashjian AH Jr, Behar J, Biancani P. Agonist independent, muscle vype specific signal transduction pathways in cat esophageal and lower esophageal sphincter (LES) circular smooth muscle. J Phgrmacol Exp Ther 1995;273:482-491.
35. Kim NY, Sohn UD, M;angannan V, Rich H, Behar J, Biancani P. Leukotrienes in ACh-induced contraction of esophageal circular smooth muscle in experimental esophagitis. Gastroenterology 1997;112:1548-1558.
36. Kirn N, Song IS, Kirn CY, Cao W, Biancani P. Leukotriene-induced contraction of cat esophageal and lower esophageal sphincter circular smooth muscle (abstr). Gastroenterology 1997;112: A760.
37. Fabiato A, Fabiato F. Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells. J Physiol 1979:75:463-505.
38. Bitar KN, Bradford P, Putney JW, Makhlouf GM. Stoichiometry of contraction and Ca2+ mobilization by inositol 1,4,5-triphosphate in isolated gastric smooth muscle cells. J Biol Chem 1986;261: 16591-16596.
39. Bitar KN, Kaminski MS, Hailat N, Cease KB, Strahler JR. HSP27 is a mediator of sustained smooth muscle contraction in response to bombesin. Biochem Biophys Res Commun 1991;181: 1192-1200.
40. Riffo M, Lahoz EG, Esponda P. Immunocytochemical localization of phospholipase A2 in hamster spermatozoa. Histochemistry 1992:97:25-31.
41. Laemmli UK. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970:227:680685.
42. Jain MK, Tap W, Rogers J, Aenson C, Eible H, Yu B-Z. Active-sitedirected specific competitive inhibitors of phospholipase A2. Biochemistry 1991:30:10256-10268.
43. Jain MK, Ghomashchi F, Yu B-Z, Bayburt T, Murphy D, Houck D, Brownell J, Reid JC, Solowiej JE, Won S-M, Mock U, Jarrell R, Sasser M, Gelb MH. Fatty acid secreted phospholipase A2. J Med Chem 1992:35:3584-3586.
44. Schütze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kranke M. TNF activates NF-kB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 1992:71:765-776.
45. Bleasdale JE, Bundy GL, Bunting S, Fitzpatric FA, Huff RM, Sun FF, Pike JE. Inhibition of phospholipase C dépendent processes by U-73,122. In: Samuelson B, Wong PYK, Sun FF, eds. Advances in prostaglandin, thromboxane and leukotriene research. New York: Raven, 1989:590-593.
46. Verheij HM, Westerman J, Sternby B, De Haas G. The complète primary structure of phospholipase A2 from human pancreas. Biochim Biophys Acta 1983:747:93-99.
47. Ohara O, Ishizaki J, Arita H. Structure and function of phospholipase A2 receptor. Prog Lipid Res 1995:34:117-138.
48. Kundu GC, Mukherjee AB. Evidence that porcine pancreatic phospholipase A2 via its high affinity receptor stimulates extracellular matrix invasion by normal and cancer cells. J Biol Chem 1997; 272:2346-2353.
49. Kishino J, Ohara O, Nomura K, Kramer RM, Arita H. Pancreatictype phospholipase A2 induces group II phospholipase A2 expression and prostaglandin biosynthesis in rat mesangeal cells. J Biol Chem 1994;269:5092-5098.
50. Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 1997; 112:1000-1016.
51. Lichtenberger LM. The hydrohobic barrier properties of gastrointestinal mucus. Annu Rev Physiol 1995:57:565-583.
52. Wallace JL, Tigley AW. New insights into prostaglandin and mucosal defense. Aliment Pharmacol Ther 1995:9:227-235.
53. Stoll AH, Weinstein WM, Kurata J, McCarthy D. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. UCLA Conference. Ann Intern Med 1991:94:439-449.
54. Barrier CH, Hirschowitz Bl. Controversies in the detection and management of nonsteroidal antiinflammatory drug-induced side effects of the upper gastrointestinal tract. Arthritis Rheum 1989; 32:926-932.
55. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell Rl. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 1992;327:749-754.
56. Bataille C, Soumagne D, Loly J, Brasinne A. Esophageal stricture due to indomethacin. Digestion 1982;24:66-68.
57. Coates AG, Nostrant TT, Wilson JAP, Elta GH, Agha FP. Esophagitis caused by nonsteroidal anti-inflammatory medication: case reports and reviews of the literature on pill-induced esophageal injury. South Med J 1986;79:1094-1097.
58. El-Serag HB, Sonnenberg A. Association of esophagitis and esophageal strictures with diseases treated with nonsteroidal anti-inflammatory drugs. Am J Gastroenterol 1997;92:52-56.
59. Exton JH. Regulation of phosphoinositide phospholipases by hor-mones, neurotransmitters, and other agonists linked to G proteins. Annu Rev Pharmacol Toxicol 1996;36:481-509.
60. Rhee SG, Bae US. Regulation of phosphoinositide-specific phospholipase C isozymes. J Biol Chem 1997;272:15045-15048.